Lexington, Massachusetts, United States
Contact Info
238 followers
238 connections
Lexington, Massachusetts, United States
Contact Info
238 followers
238 connections
About
• Antibody (monoclonal, bi-specific, scFv, llama, IgNAR) /Protein (non-antibody scaffolds…
Activity
-
It's time to recognize my favorite booths from #PEGS2024. And the overall winner goes to... Twist Bioscience - I felt Twist not only had a…
It's time to recognize my favorite booths from #PEGS2024. And the overall winner goes to... Twist Bioscience - I felt Twist not only had a…
Liked by Subhendu Chakraborti PhD
-
If you will be attending #BIO2024 next week, you will have the opportunity to meet our SVP of Drug Discovery, Malavi Madireddi! Malavi has a…
If you will be attending #BIO2024 next week, you will have the opportunity to meet our SVP of Drug Discovery, Malavi Madireddi! Malavi has a…
Liked by Subhendu Chakraborti PhD
Experience & Education
-
Mosaic Biosciences
View Subhendu’s full experience
See their title, tenure and more.
or
Publications
-
Selection and characterization of FcεRI phospho-ITAM specific antibodies.
MAbs. 2019 Jul 16:1-13
-
Rosetta comparative modeling for library design: Engineering alternative inducer specificity in a transcription factor
Proteins: Structure, Function, and Bioinformatics
-
Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin
Protein Eng Des Sel. 2011 Mar;24(3):321-31
-
Crystal Structure of Human Senescence Marker Protein 30: Insights Linking Structural, Enzymatic, and Physiological Functions
Biochemistry, 2010, 49 (16), pp 3436–3444
Other authors -
Patents
-
Antibodies for Botulinum Neurotoxins
Issued US WO2012047427 A3
Selection, affinity maturation and characterization of a panel of human monoclonal antibodies (first-in-class) binding to Botulinum neurotoxin serotype-G with picomolar affinities, by yeast display based antibody engineering methods.
Other inventors -
More activity by Subhendu
-
Welcome to the team, Scott and Malavi!
Welcome to the team, Scott and Malavi!
Liked by Subhendu Chakraborti PhD
-
📢 Exciting News from Repligen ! Check out their latest development Custom Affinity Resin with a 💯 % Ligand Discovery Success rate and an…
📢 Exciting News from Repligen ! Check out their latest development Custom Affinity Resin with a 💯 % Ligand Discovery Success rate and an…
Liked by Subhendu Chakraborti PhD
-
Last week, I attended the 2 day Cracking the Code: The Dawn of Nucleic Acid Medicines conference and I truly enjoyed all the great speakers who…
Last week, I attended the 2 day Cracking the Code: The Dawn of Nucleic Acid Medicines conference and I truly enjoyed all the great speakers who…
Liked by Subhendu Chakraborti PhD
-
Congratulations to Dr. Katalin Karikó and Dr. Drew Weissman, winners of the 2023 #NobelPrize in Medicine or Physiology, for their groundbreaking work…
Congratulations to Dr. Katalin Karikó and Dr. Drew Weissman, winners of the 2023 #NobelPrize in Medicine or Physiology, for their groundbreaking work…
Liked by Subhendu Chakraborti PhD
-
Our new interactive tables "Approved/In review antibodies" and "Antibodies in late stage studies" are online!!! Approved/In review antibodies:…
Our new interactive tables "Approved/In review antibodies" and "Antibodies in late stage studies" are online!!! Approved/In review antibodies:…
Liked by Subhendu Chakraborti PhD
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More